291 related articles for article (PubMed ID: 30637779)
1. Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.
Chen H; Gao F; He M; Ding XF; Wong AM; Sze SC; Yu AC; Sun T; Chan AW; Wang X; Wong N
Hepatology; 2019 Sep; 70(3):1011-1025. PubMed ID: 30637779
[TBL] [Abstract][Full Text] [Related]
2. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
Li X; Zhang W; Zhou L; Yue D; Su X
Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
[TBL] [Abstract][Full Text] [Related]
4. The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.
Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
[TBL] [Abstract][Full Text] [Related]
5. Aberrant regulation of alternative pre-mRNA splicing in hepatocellular carcinoma.
Liu L; Xie S; Zhang C; Zhu F
Crit Rev Eukaryot Gene Expr; 2014; 24(2):133-49. PubMed ID: 24940767
[TBL] [Abstract][Full Text] [Related]
6. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.
Huang Q; Lin B; Liu H; Ma X; Mo F; Yu W; Li L; Li H; Tian T; Wu D; Shen F; Xing J; Chen ZN
PLoS One; 2011; 6(10):e26168. PubMed ID: 22043308
[TBL] [Abstract][Full Text] [Related]
7. Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.
Dauki AM; Blachly JS; Kautto EA; Ezzat S; Abdel-Rahman MH; Coss CC
Cancer Res; 2020 Feb; 80(3):561-575. PubMed ID: 31685543
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Micropeptides Derived from Hepatocellular Carcinoma-Specific Long Noncoding RNA.
Polenkowski M; Burbano de Lara S; Allister AB; Nguyen TNQ; Tamura T; Tran DDH
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008483
[TBL] [Abstract][Full Text] [Related]
9. RNA splicing: a dual-edged sword for hepatocellular carcinoma.
Kashyap A; Tripathi G; Tripathi A; Rao R; Kashyap M; Bhat A; Kumar D; Rajhans A; Kumar P; Chandrashekar DS; Mahmood R; Husain A; Zayed H; Bharti AC; Kashyap MK
Med Oncol; 2022 Aug; 39(11):173. PubMed ID: 35972700
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.
Luo Z; Mao X; Cui W
Med Oncol; 2019 Sep; 36(10):86. PubMed ID: 31494761
[TBL] [Abstract][Full Text] [Related]
11. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells.
Cetin M; Odabas G; Douglas LR; Duriez PJ; Balcik-Ercin P; Yalim-Camci I; Sayan AE; Yagci T
Cells; 2019 Mar; 8(3):. PubMed ID: 30832318
[TBL] [Abstract][Full Text] [Related]
12. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.
Zhan YT; Li L; Zeng TT; Zhou NN; Guan XY; Li Y
Aging (Albany NY); 2020 Dec; 13(1):537-554. PubMed ID: 33289700
[TBL] [Abstract][Full Text] [Related]
13. SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH
Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894
[TBL] [Abstract][Full Text] [Related]
14. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
Niehof M; Borlak J
Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
[TBL] [Abstract][Full Text] [Related]
15. Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression.
Yan Q; Fang X; Liu X; Guo S; Chen S; Luo M; Lan P; Guan XY
Adv Sci (Weinh); 2024 Jan; 11(1):e2305653. PubMed ID: 37985644
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
17. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
18. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
19. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
20. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
